<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr13-2050312120973499">
 <label>13</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lilienfeld</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Galantamine: a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer’s disease</article-title>. 
  <source>CNS Drug Rev</source>
  <year>2002</year>; 
  <volume>8</volume>(
  <issue>2</issue>): 
  <fpage>159</fpage>–
  <lpage>176</lpage>.
  <pub-id pub-id-type="pmid">12177686</pub-id>
 </mixed-citation>
</ref>
